Sambudla’s absence at Jacob Zuma’s Arms Deal trial marks a significant shift in their longstanding father-daughter dynamic, ...

Zuma is also fighting a ruling ordering him to repay $1.6 million in state-funded legal fees from his corruption defense. He ...

Kite, a Gilead Company , presented a new analysis today demonstrating that second-line Yescarta® (axicabtagene ciloleucel) therapy offers consistent benefits in patients with relapsed/refractory large ...

"Epcoritamab and R 2 is a novel chemotherapy-free fixed-duration therapy that is suitable for outpatient administration and, we believe, sets a new benchmark as a standard of care for second-line [or ...